Clinical trial
Study of the Incidence of Jarisch-Herxheimer Reaction in Leptospirosis Patients in New Caledonia
NCT04882046 is registered in ClinicalTrials.gov with Institut Pasteur as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Incidence of Jarisch-Herxheimer Reaction in Leptospirosis Patients in New Caledonia
- Lead sponsor
- Institut Pasteur
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 23, 2021
- Completion date
- December 31, 2023
- Enrollment
- 900 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
jarisch herxheimer reaction, leptospirosis